The Transcatheter Aortic Valve Implantation (TAVI) Market report is equipped with market data from 2013 to 2023. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2018 to 2023. The detailed sales channel is also covered in the study.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
Scope of the Report:
This report focuses on the Transcatheter Aortic Valve Implantation (TAVI) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Transcatheter Aortic Valve Implantation (TAVI) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017.
Market Segment by Manufacturers, this report covers
- Edwards Lifesciences
- Medtronic
- St. Jude Medical
- Boston Scientific
- Meril Life Sciences
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Transfemoral Approach
- Transapical Approach
- Others
Market Segment by Applications, can be divided into
- Aortic Stenosis
- Aortic Regurgitation
- Others
There are 15 Chapters to deeply display the global Transcatheter Aortic Valve Implantation (TAVI) market.
Chapter 1, to describe Transcatheter Aortic Valve Implantation (TAVI) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Transcatheter Aortic Valve Implantation (TAVI), with sales, revenue, and price of Transcatheter Aortic Valve Implantation (TAVI), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Transcatheter Aortic Valve Implantation (TAVI), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Transcatheter Aortic Valve Implantation (TAVI) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Transcatheter Aortic Valve Implantation (TAVI) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source